BamSEC and AlphaSense Join Forces
Learn More

Biogen Inc.

NASDAQ: BIIB    
Share price (12/20/24): $146.47    
Market cap (12/20/24): $21.3 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from S-8 2 pages Certificate of Amendment to the Certificate of Incorporation of Biogen Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware Article X
12/34/56
EX-4.6
from 10-K 1 page Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.8
from 10-K 28 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from 8-K 22 pages Registration Rights Agreement
12/34/56
EX-4.4
from 8-K 11 pages 3.250% Senior Note Due 2051
12/34/56
EX-4.3
from 8-K 10 pages 3.250% Senior Note Due 2051
12/34/56
EX-4.2
from 8-K 38 pages Biogen Inc., as Issuer and U.S. Bank National Association, as Trustee Third Supplemental Indenture Dated as of February 16, 2021
12/34/56
EX-4.4
from 10-K 28 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 34 pages Biogen Inc., as Issuer and U.S. Bank National Association, as Trustee Second Supplemental Indenture Dated as of April 30, 2020
12/34/56
EX-4.4
from 10-K 15 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 50 pages Biogen Inc., as Issuer and U.S. Bank National Association, as Trustee First Supplemental Indenture Dated as of September 15, 2015
12/34/56
EX-4.1
from 8-K 48 pages Biogen Inc. and U.S. Bank National Association, as Trustee Indenture Debt Securities Dated as of September 15, 2015
12/34/56
EX-4.1
from S-3ASR 47 pages Biogen Inc. and U.S. Bank National Association, as Trustee Indenture Debt Securities Dated as Of
12/34/56
EX-4.4
from 10-K 2 pages Amendment No. 2 to Amended and Restated Rights Agreement
12/34/56
EX-4.1
from 8-K 2 pages Amendment No. 2 to Amended and Restated Rights Agreement
12/34/56
EX-4.1
from 8-K 34 pages Biogen Idec Inc., as Issuer and the Bank of New York Trust Company, N.A., as Trustee First Supplemental Indenture Dated as of March 4, 2008
12/34/56
EX-4.1
from S-3ASR 52 pages Biogen Idec Inc. and the Bank of New York Trust Company, N.A., as Trustee Indenture Debt Securities Dated as of February 26, 2008
12/34/56
EX-4.2
from 10-K 1 page Ex-4.2 Specimen Common Stock Certificate
12/34/56
EX-4.1
from 8-K 1 page Amendment No. 1 to Amended and Restated Rights Agreement
12/34/56
EX-4.3
from 10-Q 15 pages For Purposes of Sections 1272, 1273 and 1275 of the Internal Revenue Code of 1986, as Amended, This Security Is Being Issued With Original Issue Discount and the Issue Date of This Security Is April April 29, 2002. in Addition, This Security Is Subject to United States Federal Income Tax Regulations Governing Contingent Payment Debt Instruments. Under Such Regulations, the Comparable Yield of This Security Is 8.51% (Which Will Be Treated as the Yield for United States Federal Income Tax Purposes), Compounded Semiannually. the Yield for Accruing Original Issue Discount for Non-Tax Purposes Is 1.75%, Compounded Semiannually
12/34/56